Amy Duross - Net Worth and Insider Trading

Amy Duross Net Worth

The estimated net worth of Amy Duross is at least $516,136 dollars as of 2024-04-28. Amy Duross is the Director of BioLife Solutions Inc and owns about 29,443 shares of BioLife Solutions Inc (BLFS) stock worth over $516,136. Details can be seen in Amy Duross's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Amy Duross has not made any transactions after 2024-03-13 and currently still holds the listed stock(s).

Transaction Summary of Amy Duross

To

Amy Duross Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Amy Duross owns 1 companies in total, including BioLife Solutions Inc (BLFS) .

Click here to see the complete history of Amy Duross’s form 4 insider trades.

Insider Ownership Summary of Amy Duross

Ticker Comapny Transaction Date Type of Owner
BLFS BioLife Solutions Inc 2024-03-13 director

Amy Duross Latest Holdings Summary

Amy Duross currently owns a total of 1 stock. Amy Duross owns 29,443 shares of BioLife Solutions Inc (BLFS) as of March 13, 2024, with a value of $516,136.

Latest Holdings of Amy Duross

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BLFS BioLife Solutions Inc 2024-03-13 29,443 17.53 516,136

Holding Weightings of Amy Duross


Amy Duross Form 4 Trading Tracker

According to the SEC Form 4 filings, Amy Duross has made a total of 2 transactions in BioLife Solutions Inc (BLFS) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in BioLife Solutions Inc is the sale of 11,200 shares on March 13, 2024, which brought Amy Duross around $189,504.

Insider Trading History of Amy Duross

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Amy Duross Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Amy Duross Ownership Network

Ownership Network List of Amy Duross

No Data

Ownership Network Relation of Amy Duross


Amy Duross Owned Company Details

What does BioLife Solutions Inc do?

Who are the key executives at BioLife Solutions Inc?

Amy Duross is the director of BioLife Solutions Inc. Other key executives at BioLife Solutions Inc include VP & Global Human Resources Sarah Aebersold , Chief Tech. Officer & Sr. VP Aby J. Mathew , and Vice President & Marketing Todd Berard .

BioLife Solutions Inc (BLFS) Insider Trades Summary

Over the past 18 months, Amy Duross made no insider transaction in BioLife Solutions Inc (BLFS). Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 162,286 shares made by Aby J. Mathew , a net sale of 48,159 shares made by Todd Berard , and a net sale of 16,114 shares made by Karen A. Foster .

In summary, during the past 3 months, insiders sold 73,911 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 73,911 shares. During the past 18 months, 530,204 shares of BioLife Solutions Inc (BLFS) were sold and 1,135,630 shares were bought by its insiders, resulting in a net purchase of 605,426 shares.

BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioLife Solutions Inc Insider Transactions

No Available Data

Amy Duross Mailing Address

Above is the net worth, insider trading, and ownership report for Amy Duross. You might contact Amy Duross via mailing address: 8410 Golden Bear Place, Whistler A1 V8e 1j7.

Discussions on Amy Duross

No discussions yet.